Tectonic Therapeutic (TECX) Total Current Liabilities (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Total Current Liabilities of $13.0 million for Q1 2026, up 34.06% quarter-over-quarter from $9.7 million in Q4 2025.
Analysis
Tectonic Therapeutic (TECX) Total Current Liabilities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Total Current Liabilities for 10 consecutive years, with $13.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities changed N/A year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $13.0 million (changed N/A YoY), while the FY2025 annual figure was $9.7 million, down 16.74% from the prior year.
- Total Current Liabilities advanced to $13.0 million in Q1 2026 per TECX's latest filing, from $9.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $40.9 million in Q4 2023 and bottomed at $3.5 million in Q1 2024.
- Historically, Total Current Liabilities has averaged $14.7 million across 5 years, with a median of $12.9 million in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 211.77% — and 2024, when it tumbled 75.46%.
- Tectonic Therapeutic's Total Current Liabilities stood at $13.1 million in 2022, then surged by 211.77% to $40.9 million in 2023, then plunged by 71.61% to $11.6 million in 2024, then declined by 16.74% to $9.7 million in 2025, then jumped by 34.06% to $13.0 million in 2026.
- Business Quant data shows TECX's Total Current Liabilities at $13.0 million in Q1 2026, $9.7 million in Q4 2025, and $9.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | 10.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.37 Mn |
| Mar 31, 2026 | 12.96 Mn |
| Dec 31, 2025 | 9.67 Mn |
| Sep 30, 2025 | 9.37 Mn |
| Jun 30, 2025 | 11.36 Mn |
| Mar 31, 2025 | 13.51 Mn |
| Dec 31, 2024 | 11.61 Mn |
| Sep 30, 2024 | 17.32 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 40.89 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | 11.66 Mn |
| Mar 31, 2023 | 14.30 Mn |
| Dec 31, 2022 | 13.12 Mn |
| Sep 30, 2022 | 16.19 Mn |
| Jun 30, 2022 | 12.79 Mn |
| Mar 31, 2022 | 17.13 Mn |
| Dec 31, 2021 | 19.39 Mn |
| Sep 30, 2021 | 22.79 Mn |